{"id":2890,"date":"2016-12-07T23:34:02","date_gmt":"2016-12-07T23:34:02","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=18659"},"modified":"2016-12-07T23:34:02","modified_gmt":"2016-12-07T23:34:02","slug":"axim-biotechnologies-receives-committee-approval-begin-ibs-studies","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/","title":{"rendered":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies"},"content":{"rendered":"

AXIM\u00ae Biotechnologies, a Medical Marijuana, Inc. investment company, is back in the news again this week, revealing that the company has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum. <\/span><\/p>\n

Following a wave of positive achievements announced by the company this year, driving its stock price to 2000 percent gains year over date, AXIM\u00ae Biotechnologies<\/a> reported this week that they received approval from the Medical Ethical Committee (METC) of Wageningen University, located in The Netherlands, to begin a study on patients suffering from irritable bowel syndrome (IBS) featuring its CanChew\u00ae Plus CBD gum.<\/span><\/p>\n

The METC at Wageningen University, an institutional approval board that is compliant with the Ethical Principles for Medical Research, is responsible for reviewing and approving applications for clinical studies to be performed at the school. According to the Times Higher Education World University Rankings, Wageningen is <\/span>the top university in The Netherlands<\/span><\/a>. <\/span><\/p>\n

In discussing the recent news, Medical Marijuana, Inc. CEO <\/span>Dr. Stuart Titus<\/span><\/a> said, \u201cIt is the goal of AXIM\u00ae and our entire family of companies to help people suffering from various gastrointestinal disorders with no effective remedies such as IBS. Positive outcomes from these type of studies can help in the immediate need to enter trials for inflammatory bowel disease<\/a> (IBD) and Crohn\u2019s disease<\/a>.\u201d<\/span><\/p>\n

Irritable bowel syndrome is a common disorder that affects around <\/span>11 percent<\/span><\/a> of the world\u2019s population, striking women under 50 more than any other group. IBS, affecting the large intestine, commonly causes cramping, abdominal pain, bloating, gas, diarrhea and constipation. IBS is a chronic condition that requires long-term management. However, the condition’s impact on a patient\u2019s overall quality of life may be the most significant complication, leading to a demand for effective treatments to ease the suffering of affected patients. <\/span><\/p>\n

Dr. Titus continued, \u201cWith the global treatment market for irritable bowel syndrome <\/span>estimated to grow in value to $1.5 billion by 2023<\/span><\/a>, cannabis-based products like CanChew\u00ae Plus can provide viable solutions for patients suffering from some of the most common of functional gastrointestinal disorders.\u201d<\/span><\/p>\n

AXIM\u00ae Biotechnologies is looking to utilize the human body\u2019s natural endocannabinoid system, which is responsible for maintaining homeostasis among our systems, and their patent on delayed-release chewing gum as a delivery method for cannabinoids to create a novel new treatment solution for those living with IBS. <\/span><\/p>\n

The company\u2019s IBS study is just one of several clinical studies AXIM\u00ae Biotechnologies is looking to undertake. Earlier in the year, AXIM\u00ae announced that it had <\/span>secured the necessary funding<\/span><\/a> to move forward with a group of cannabinoid-based clinical trials, including trials on its MedChew\u00ae RX, CanChew\u00ae Plus, and AX-1602 topically applied cannabinoid ointment. The company also published a <\/span>development pipeline chart<\/span><\/a> to reveal their new drug schedule for the coming months and years.<\/span><\/p>\n

Keep up to date with news from AXIM\u00ae Biotechnologies and other Medical Marijuana, Inc. investments by following <\/span>our news feed<\/span><\/a>. <\/span> \t<\/p>\n","protected":false},"excerpt":{"rendered":"

AXIM\u00ae Biotechnologies, a Medical Marijuana, Inc. investment company, is back in the news again this week, revealing that the company has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum. Following a wave of positive achievements announced by the company this year, driving its stock price to […]<\/p>\n","protected":false},"author":1,"featured_media":212,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3],"tags":[],"class_list":["post-2890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news"],"yoast_head":"\nAXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.<\/title>\n<meta name=\"description\" content=\"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-07T23:34:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-adding-samples-11-08-16-ver1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies\",\"datePublished\":\"2016-12-07T23:34:02+00:00\",\"dateModified\":\"2016-12-07T23:34:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\"},\"wordCount\":491,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"articleSection\":[\"Axim Biotechnologies\",\"Company News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\",\"name\":\"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2016-12-07T23:34:02+00:00\",\"dateModified\":\"2016-12-07T23:34:02+00:00\",\"description\":\"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.","description":"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/","og_locale":"en_US","og_type":"article","og_title":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.","og_description":"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.","og_url":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2016-12-07T23:34:02+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-adding-samples-11-08-16-ver1.png","type":"image\/png"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies","datePublished":"2016-12-07T23:34:02+00:00","dateModified":"2016-12-07T23:34:02+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/"},"wordCount":491,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"articleSection":["Axim Biotechnologies","Company News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/","url":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/","name":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2016-12-07T23:34:02+00:00","dateModified":"2016-12-07T23:34:02+00:00","description":"AXIM\u00ae Biotechnologies has gained the approval necessary to start next phase clinical trials for its CanChew\u00ae Plus cannabinoid-infused chewing gum.","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2016\/12\/07\/axim-biotechnologies-receives-committee-approval-begin-ibs-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"AXIM\u00ae Biotechnologies Receives Committee Approval to Begin IBS Studies"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=2890"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/212"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=2890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=2890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=2890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}